Landscapes / Targets
aldosterone synthase
3 drugs act on aldosterone synthase, in 10 active trials · Any stage · updated 20 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Aldosterone synthase inhibitor |
AstraZeneca · Public AZN |
Approved | 10 Dec 2026soonPhase 2 trial completes | ||
| Next date | 10 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Chronic Kidney Disease and Hypertension, Heart Failure and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Hypertension | ||||
| Open drug page | |||||
— |
Phase 2 | 22 Jul 2027Phase 2 trial completes | |||
| Next date | 22 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Uncontrolled Hypertension, Resistant Hypertension and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · openFDA updated 20 Nov 2026